PDS Biotechnology Corporation (PDSB)
NASDAQ·Healthcare·Biotechnology
$1.10
+17.74%
Mkt Cap $37.49M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+721.9%
Consensus $9.00 vs current $1.10
NASDAQ·Healthcare·Biotechnology
$1.10
+17.74%
Mkt Cap $37.49M
No recent rating data.
Price Target (2 analysts)
$9.00
Range $9.00 – $9.00
+721.9%
Consensus $9.00 vs current $1.10